Combination Appetite Therapy
Investigational injectable treatments combining an amylin analogue with a GLP-1 receptor agonist to target several appetite pathways at once.
Plain English
Patient-Friendly Explanation
Combination appetite therapy uses two or more medications with different mechanisms to control hunger, so smaller doses can work better with fewer side effects. It is prescribed only after a full medical assessment and is always combined with diet and lifestyle changes.
Medical
Clinical Definition
Combination pharmacotherapy for obesity pairs agents with complementary or synergistic mechanisms — for example, an opioid-receptor antagonist with a dopamine/noradrenaline reuptake inhibitor, or a GLP-1 receptor agonist combined with other appetite-regulating agents. The rationale is that targeting multiple appetite pathways — reward, homeostatic and gastrointestinal — can improve efficacy while allowing lower doses of each component. The fixed-dose naltrexone/bupropion combination is one established example, and other dual and triple incretin-based combinations are in clinical development. Combinations are reserved for patients who meet clinical criteria for pharmacotherapy, with monitoring of blood pressure, mood and gastrointestinal effects.
Key Insight
Why It Matters
One medication does not fit every appetite. Combining treatments lets our doctors match the therapy to how your hunger actually works — with regular reviews to keep it safe and effective.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: August 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
